As part of their work for North Thames Research and Development, the King's Fund collected data on all Betaferon users from December 1995 to September 1996 in the North Thames region. They also organised discussion groups with 24 potential or actual users of the drug. The report looks at who ...
This report addresses two questions: which factors influence people with relapsing remitting MS to come forward for new drug therapies?, and what do these group of people with MS want from an organisation such as the Multiple Sclerosis Society (MSS)? In addressing the first question, the authors discuss various discouraging ...